Bessemer Group Inc Abb Vie Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 1,285,767 shares of ABBV stock, worth $225 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

1,285,767

Previous 1,280,138 0.44%

Holding current value

$225 Million

Previous $220 Million 15.64%

% of portfolio

0.42%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $922,255 - $1.12 Million	5,629 Added 0.44%	1,285,767 $254 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $7.48 Million - $8.73 Million	-48,319 Reduced 3.64%	1,280,138 $220 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $8.34 Million - $9.5 Million	-52,182 Reduced 3.78%	1,328,457 $242 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $1.62 Million - $1.82 Million	11,770 Added 0.86%	1,380,639 $214 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $67.3 Million - $78 Million	-504,140 Reduced 26.92%	1,368,869 $204 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $174,780 - $217,503	-1,319 Reduced 0.07%	1,873,009 $252 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $2.23 Million - $2.57 Million	15,413 Added 0.83%	1,874,328 $299 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $3.25 Million - $3.89 Million	23,476 Added 1.28%	1,858,915 $300 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $27.1 Million - $31.1 Million	-201,939 Reduced 9.91%	1,835,439 $246 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $4.32 Million - $5.49 Million	31,389 Added 1.56%	2,037,378 $312 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $2.95 Million - $3.67 Million	22,384 Added 1.13%	2,005,989 $325 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $22.6 Million - $28.6 Million	210,403 Added 11.87%	1,983,605 $269 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1.57 Million - $1.78 Million	14,759 Added 0.84%	1,773,202 $191 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $24 Million - $26.7 Million	227,939 Added 14.89%	1,758,443 $198 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $10.7 Million - $11.8 Million	104,687 Added 7.34%	1,530,504 $166 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $785,823 - $1.06 Million	9,763 Added 0.69%	1,425,817 $153 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $13 Million - $15.3 Million	151,599 Added 11.99%	1,416,054 $124 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $3.46 Million - $4.62 Million	47,104 Added 3.87%	1,264,455 $124 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $17.9 Million - $27.1 Million	277,451 Added 29.52%	1,217,351 $92.8 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $2.37 Million - $2.97 Million	-32,868 Reduced 3.38%	939,900 $83.2 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $97,493 - $117,214	-1,548 Reduced 0.16%	972,768 $73.7 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $16,359 - $20,911	249 Added 0.03%	974,316 $70.9 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $2.04 Million - $2.4 Million	26,424 Added 2.79%	974,067 $78.5 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $71.5 Million - $88.2 Million	918,170 Added 3115.29%	947,643 $87.4 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $39,031 - $43,390	439 Added 1.51%	29,473 $2.79 Million
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $254,256 - $300,843	-2,832 Reduced 8.89%	29,034 $2.69 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $46,373 - $62,097	-504 Reduced 1.56%	31,866 $3.02 Million
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $439,829 - $482,309	-4,911 Reduced 13.17%	32,370 $3.13 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $2.6 Million - $3.33 Million	37,281	37,281 $3.31 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Abb Vie Inc. Transaction History